Now you can have what she’s having...
Drug tested as new anti-depressant is hailed instead as 'Viagra for women'
Monday 16 November 2009
Latest in Consummation
Related articles
On Facebook
Life & Style blogs
Living a long, healthy life – looking after your heart
In my clinic I see all sorts of people walking through my door. Mostly, they come to me because they...
Tips on renting your property to students
Five important things to think about before the Freshers arrive...
As the old joke has it, men can be turned on with a simple flick of a switch while women require attention to a battery of dials and buttons. Today the debate over how to stimulate female sexual desire is set to be reopened with the discovery of a drug described as “Viagra for women”.
Doctors testing a new anti-depressant found it was useless as a mood brightener - but was unexpectedly effective at boosting the female libido.
Now three clinical trials have shown that the drug fibanserin significantly improved sexual desire and satisfaction in women.
The accidental discovery mirrors that of Viagra, which was being tested as a heart medicine in the 1990s when the male subjects prescribed it discovered it had a pleasing side effect.
However, fibanserin is different in that it works on the brain rather than on the genitals, according to John Thorp, professor of obstetrics and gynaecology at the University of North Carolina. Doctors have long known that in women, the brain is the most important sex organ.
Professor Thorp, who led the studies, said: “It’s essentially a Viagra-like drug for women in that diminished desire or libido is the most common feminine sexual problem, like erectile sexaul dysfunction is in men.”
“Fibanserin was a poor antidepressant. However, astute observers noted that it increased libido in laboratory animals and human subjects. So we conducted multiple clinical trials and the women in our studies who took it for hypoactive sexual desire disorder [low libido] reported significant improvements in sexual desire and satisfactory sexual experiences.”
The trial results were presented yesterday at the Congress of the European Society for Sexual Medicine in Lyon, France. Funded by Boehringer Ingelheim, manufacturer of fibanserin, the trials and were carried out among 2,000 women in the US, Canada and Europe, using four different doses of the drug. However, only the highest dose of 100 mgs a day was found to be effective.
Women taking the 100 mg dose reported having more frequent and more satisfying sex and greater desire. They were also less distressed about their previous sexual problems.
Professor Thorp said the only currently available treatment for low sexual desire in women was testosterone patches. Although testosterone is a male hormone, it is also produced in women at lower levels and plays a crucial role in sexual desire.However, it has unpleasant side effects, including acne and facial hair growth.
“These results point to a novel approach to pharmacological treatment of the sexual problem that plagues reproductive age women the most,” he said.
Previous research has suggested that between one in ten and one in four women suffers from low libido, which varies with age and whether they are pre- or post-menopause.
But critics have claimed that drug companies have exaggerated the extent of women's sexual problems to create new markets. The feminist author and sex researcher Shere Hite has said: “It is not arousal pills we need but a whole new kind of physical relations. The pharmaceutical industry is guilty not just of cynical money-grabbing exaggeration, it has misunderstood the basics of female sexuality.”
Specialists in sexual medicine agree that the female libido is more complex than the male libido, but claim it can respond to gentle hormonal stimulation.
However Irwin Nazareth, from the Royal Free and University College Medical School, London, said sexual dysfunction needs to be redefined.
In a survey of 1,000 women in north London six years ago, he found that while 40 per cent reported a lack of or loss of sexual desire, only a quarter regarded it as a problem. “For many people, reduced sexual interest or response may be a normal adaptation,” he said.
- 1 The Ten Best Places In The World To Be Gay
- 2 So Moorish: Mark Hix offers his own take on classic Moroccan dishes
- 3 The 10 Best Scotch Whiskies
- 4 Private viewing: Our tour of the pick of the property market
- 5 The Ten Best Ice Cream Makers
- 6 The Ten Best Men's Sunglasses
- 7 The Ten Best Steam Irons
- 8 African monkey meat that could be behind the next HIV
- 9 Liver disease 'time bomb' warning
- 10 Coke reveals its secret: It may need to carry a cancer warning
- 1 Mark Zuckerberg saved $111m by selling Facebook shares before stock slumped
- 2 Osborne adviser leaked budget information to Murdoch's man
- 3 Brazil rocked by abortion for 9-year-old rape victim
- 4 Society: The only way is Finland
- 5 Schoolboy spiked brownies with cannabis in cookery class
- 6 Fat? Really? Olympic hope laughs off official’s jibe – but others aren’t amused
- 7 'Hello mum, this is going to be hard for you to read ...'
- 8 African monkey meat that could be behind the next HIV
- 9 Coke reveals its secret: It may need to carry a cancer warning
- 10 French in uproar over oral sex anti-smoking posters
Experience the Heineken Hub
Get free wi-fi and exclusive i content while you enjoy a tasty pint of Heineken at participating pubs.
Can you imagine a career in teaching?
Be inspired to teach - let real teachers show you how rewarding the job can be.
Playing a game-changing role during the Games
Cisco is providing the solutions for London 2012's complex IT needs.
Enter the latest Independent competitions
Win anything from gadgets to five-star holidays on our competitions and offers page.
Business videos from commercial thought leaders
Watch the best in the business world give their insights into the world of business.
Career Services
Ridley Scott: The most macho man in movies?
Gallic gourmets put France back on culinary map
The outsider: Margaret Howell
For men only: A pilgrimage to Mount Athos
Feeding a hungry world – or meddling with laws of nature?




Comments